Blue chip ASX healthcare share “really attractive”: top analyst

ASX healthcare shares didn’t, as a whole, have the best of years in 2020.

In fact, Randal Jenneke – head of Australian equities at the US investment firm T Rowe Price – says healthcare just suffered through its worst year in a decade.

But…